|Bid||70.23 x 800|
|Ask||70.31 x 1300|
|Day's Range||66.57 - 70.98|
|52 Week Range||27.77 - 116.91|
|Beta (5Y Monthly)||1.39|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Beam Therapeutics Inc. (BEAM) delivered earnings and revenue surprises of 5.56% and 26.87%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Beam Therapeutics Inc. ( NASDAQ:BEAM ) shareholders will doubtless be very grateful to see the share price up 78% in...
Faced with conflicting signs from all sides of the biotech economy, executives are left sorting out how to plan for growth.